Immunophenotypic variations in hairy cell leukemia

被引:61
作者
Chen, YH
Tallman, MS
Goolsby, C
Peterson, L
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA
关键词
immunophenotype; flow cytometry; hairy cell leukemia;
D O I
10.1309/PMQXVY619Q8Y43AR
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Hairy cell leukemia (HCL) exhibits a characteristic immunophenotypic profile that is strongly positive for pan-B-cell markers; positive for CD103, CD11c, and CD25; and usually negative for CD5, CD10, and CD23. We evaluated 35 HCL cases and identified atypical immunophenotypes in 12 cases (34%), including CD103- in 2 (6%), CD25- in 1 (3%), CD10+ in 5 (14%), and CD23+ in 6 (17%) cases. Among these cases one was CD103-/CD10+ and one was CD10+/CD23+. All available specimens from the 12 cases were reviewed and showed morphologic features characteristic for HCL. The initial clinical information was reviewed and showed no significant differences with that reported for typical HCL. Of the 12 cases, 11 patients received purine analogue therapy and achieved complete remissions. Our study indicates that it is not uncommon for HCL to display an unusual immunophenotype, including negativity for CD103 or CD25. Recognizing the variability of immunophenotype and correlating with morphologic and clinical features are essential for establishing an accurate diagnosis of HCL.
引用
收藏
页码:251 / 259
页数:9
相关论文
共 31 条
[11]   Analysis of CD10+ hairy cell leukemia [J].
Jasionowski, TM ;
Hartung, L ;
Greenwood, JH ;
Perkins, SL ;
Bahler, DW .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (02) :228-235
[12]   An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine [J].
Jehn, U ;
Bartl, R ;
Dietzfelbinger, H ;
Haferlach, T ;
Heinemann, V .
LEUKEMIA, 2004, 18 (09) :1476-1481
[13]  
JULIUSSON G, 1994, BLOOD, V83, P3672
[14]   Responses in refractory hairy cell leukemia to a recombinant immunotoxin [J].
Kreitman, RJ ;
Wilson, WH ;
Robbins, D ;
Margulies, I ;
Stetler-Stevenson, M ;
Waldmann, TA ;
Pastan, I .
BLOOD, 1999, 94 (10) :3340-3348
[15]  
Maloum K, 1998, BRIT J HAEMATOL, V101, P171
[16]   The variant form of hairy-cell leukaemia [J].
Matutes, E ;
Wotherspoon, A ;
Catovsky, D .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (01) :41-56
[17]   Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes [J].
Miranda, RN ;
Cousar, JB ;
Hammer, RD ;
Collins, RD ;
Vnencak-Jones, CL .
HUMAN PATHOLOGY, 1999, 30 (03) :306-312
[18]   Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL) [J].
Monaghan, SA ;
Peterson, LC ;
James, C ;
Marszalek, L ;
Khoong, A ;
Bachta, DJ ;
Karpus, WJ ;
Goolsby, CL .
CYTOMETRY PART B-CLINICAL CYTOMETRY, 2003, 56B (01) :30-42
[19]   TIA-1 expression in hairy cell leukemia [J].
Mori, N ;
Murakami, YI ;
Shimada, S ;
Iwamizu-Watanabe, S ;
Yamashita, Y ;
Hasegawa, Y ;
Kojima, H ;
Nagasawa, T .
MODERN PATHOLOGY, 2004, 17 (07) :840-846
[20]   CD52 expression in hairy cell leukemia [J].
Quigley, MM ;
Bethel, KJ ;
Sharpe, RW ;
Saven, A .
AMERICAN JOURNAL OF HEMATOLOGY, 2003, 74 (04) :227-230